| 2/21/2025 | BKIG | Fitch rates American Medical notes A-
|
| 2/21/2025 | BKIG | S&P gives A- to American Medical notes
|
| 2/21/2025 | BKIG | Moody's gives American Medical notes Baa1
|
| 2/19/2025 | BKIG | S&P ups Boston Scientific
|
| 2/19/2025 | BKIG | Fitch lifts Boston Scientific
|
| 11/20/2024 | BKIG | Moody’s views Boston Scientific, AMS positively
|
| 10/8/2024 | SP | New Issue: GS Finance prices $3.83 million PLUS notes linked to stock basket
|
| 8/22/2024 | SP | New Issue: JPMorgan prices $1.43 million return notes linked to basket of 20 stocks
|
| 2/27/2024 | SP | New Issue: RBC prices $3.88 million notes linked to basket of 20 Raymond James stock picks
|
| 2/27/2024 | SP | New Issue: RBC prices $15.68 million notes linked to basket of 20 Raymond James stock picks
|
| 2/22/2024 | BKIG | S&P assigns American Medical notes BBB+
|
| 2/22/2024 | BKIG | Moody’s gives American Medical notes Baa1
|
| 2/22/2024 | BKIG | Fitch rates American Medical notes BBB+
|
| 8/29/2023 | SP | New Issue: RBC prices $2.79 million notes linked to Raymond James securities selections
|
| 8/29/2023 | SP | New Issue: RBC prices $561,000 notes linked to Raymond James securities selections
|
| 6/28/2023 | SP | New Issue: JPMorgan prices $1.58 million return notes linked to basket of 20 stocks
|
| 5/11/2023 | SP | New Issue: HSBC prices $100,000 autocallable contingent income barrier notes on Boston Scientific
|
| 4/14/2023 | SP | New Issue: RBC prices $19.64 million notes linked to Raymond James 2023 best picks basket
|
| 4/14/2023 | SP | New Issue: RBC prices $36.7 million notes linked to Raymond James 2023 best picks basket
|
| 1/24/2023 | SP | New Issue: CIBC prices $1.05 million Accelerated Return Notes on basket of healthcare stocks
|
| 12/30/2022 | LM | Outlook 2023: Ukraine debt deferral leads overall smaller year in LM exercises
|
| 12/7/2022 | BKCVIG | S&P upgrades Boston Scientific
|
| 12/6/2022 | BKCVIG | Fitch boosts Boston Scientific
|
| 3/16/2022 | IGLM | Boston Scientific gives early results, pricing of tender, lifts cap to $2.85 billion
|
| 3/16/2022 | IGLM | Boston Scientific gives early results of tender offer, lifts tender amount to $2.85 billion
|
| 3/3/2022 | BKCVIG | Moody's gives American Medical notes Baa1
|
| 3/3/2022 | BKCVIG | S&P assigns American Medical notes BBB
|
| 3/3/2022 | BKCVIG | Fitch gives American Medical notes BBB
|
| 3/2/2022 | BKCVIG | S&P turns Boston Scientific view to positive
|
| 3/2/2022 | IGLM | Boston Scientific tenders for up to $2.5 billion notes from 13 series
|
| 2/23/2022 | BKCVIG | Moody's boosts Boston Scientific
|
| 12/6/2021 | BKCVIG | Fitch turns Boston Scientific view to positive
|
| 11/22/2021 | SP | New Issue: Barclays prices $567,000 notes linked to Pfizer, Boston Scientific, Intellia
|
| 11/22/2021 | SP | New Issue: UBS sells $8.5 million trigger autocallable contingent yield notes on stock basket
|
| 8/16/2021 | SP | New Issue: UBS prices $10 million trigger autocallable contingent yield notes on ten-stock basket
|
| 6/24/2021 | BKIG | Boston Scientific plans some debt for Farapulse acquisition
|
| 6/7/2021 | SP | New Issue: UBS prices $10.98 million trigger autocallable contingent yield notes on stock basket
|
| 5/27/2021 | BKCVIG | S&P boosts Boston Scientific
|
| 5/12/2021 | SP | Market Commentary: UBS’ $10.1 million trigger autocalls offer diversified bet on economic rebound via basket
|
| 5/10/2021 | SP | New Issue: UBS prices $10.1 million trigger autocallable contingent yield notes on stock basket
|
| 5/2/2021 | SP | New Issue: GS Finance sells $520,000 leveraged notes on basket of 82 stocks
|
| 4/20/2021 | SP | New Issue: UBS prices $11.4 million trigger autocallable contingent yield notes on stock basket
|
| 2/22/2021 | SP | New Issue: GS Finance sells $5 million leveraged notes on basket of 78 stocks
|
| 2/17/2021 | SP | New Issue: Credit Suisse sells $711,000 contingent coupon autocallable reverse converts on stocks
|
| 1/24/2021 | SP | New Issue: UBS sells $1.19 million trigger autocallable contingent yield notes on two stocks
|
| 1/17/2021 | SP | New Issue: UBS prices $3.49 million trigger autocallable contingent notes on Boston Scientific
|
| 12/16/2020 | SP | New Issue: BMO prices $29.00 million notes on Raymond James Best Picks for 2021
|
| 12/16/2020 | SP | New Issue: BMO prices $57.18 million notes on Raymond James Best Picks for 2021
|
| 10/11/2020 | SP | New Issue: Scotia sells $3.29 million capped enhanced participation notes on basket of 79 stocks
|
| 7/21/2020 | SP | New Issue: JPMorgan sells $1.37 million trigger autocallable contingent yield notes on stock
|
| 6/15/2020 | SP | New Issue: Citigroup price $623,000 digital upside reset buffer securities linked to three stocks
|
| 6/2/2020 | SP | Citi eyes digital upside reset buffer securities linked to three stocks
|
| 5/27/2020 | CV | Boston Scientific greenshoe exercised in full, ups convertible preferreds to $1.01 billion
|
| 5/22/2020 | CV | Market Commentary: Boston Scientific, Under Armour, Five9 expand on debut; Penn Gaming skyrockets
|
| 5/22/2020 | CV | Market Commentary: Morning Commentary: Boston Scientific, Under Armour, Five9 make their aftermarket debuts
|
| 5/22/2020 | CV | New Issue: Boston Scientific prices $875 million convertible preferreds to yield 5.5%, up 22.5%
|
| 5/21/2020 | CV | Market Commentary: Boston Scientific, Under Armour, Five9 eyed; Becton Dickinson, Cryoport trade higher
|
| 5/21/2020 | CV | Market Commentary: Morning Commentary: Boston Scientific, Under Armour, Five9 eyed; Becton Dickinson active
|
| 5/20/2020 | CV | Market Commentary: Boston Scientific on tap; Cryoport, Becton Dickinson in focus; new deals trade higher
|
| 5/20/2020 | CV | Boston Scientific talks $750 million convertible preferreds at 5.25%-5.75%, up 17.5%-22.5%
|
| 5/15/2020 | IG | New Issue: Boston Scientific details $1.7 billion of senior notes in two parts
|
| 5/14/2020 | EMHYPFPV | Market Commentary: Honeywell, Raytheon, Boston Scientific, Manulife, Antares price; high-grade inflows down
|
| 5/14/2020 | IG | Market Commentary: Honeywell, Raytheon, Boston Scientific, Manulife, Antares price; high-grade inflows down
|
| 5/14/2020 | IG | New Issue: Boston Scientific prices $1.7 billion of senior notes in two tranches
|
| 5/14/2020 | BKIG | Fitch assigns Boston Scientific notes BBB
|
| 5/14/2020 | IG | Market Commentary: Morning Commentary: Honeywell, Boston Scientific, PPG, Raytheon, Bank of America on tap
|
| 5/14/2020 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 5/14/2020 | BKIG | Moody’s assigns Boston Scientific notes Baa2
|
| 5/14/2020 | IG | Boston Scientific plans to sell fixed-rate senior notes in two parts
|
| 4/24/2020 | SP | New Issue: Citigroup prices $500,000 barrier securities on Boston Scientific, Medtronic
|
| 4/21/2020 | BK | Boston Scientific gets $1.25 billion 364-day loan, amends facilities
|
| 2/27/2020 | BK | Boston Scientific enters into $1 billion 364-day term loan
|
| 2/17/2020 | SP | New Issue: JPMorgan sells $429,000 autocallable contingent interest notes on stocks
|
| 12/5/2019 | BK | Boston Scientific enters into $700 million 364-day term loan
|
| 11/5/2019 | IGLM | Boston Scientific prices, posts early results of capped tender offer
|
| 11/5/2019 | IGLM | Boston Scientific posts early results of capped tender for four series
|
| 10/22/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
| 10/22/2019 | IGLM | Boston Scientific tenders for up to $1 billion notes from four series
|
| 9/5/2019 | SP | New Issue: RBC sells $323,000 contingent coupon barrier autocalls on two stocks
|
| 8/27/2019 | SP | New Issue: CIBC prices $390,000 notes linked to 30 stocks picked by Raymond James
|
| 8/19/2019 | BK | Boston Scientific draws from term loans to fund BTG acquisition
|
| 8/15/2019 | SP | RBC plans contingent coupon barrier autocallables on two stocks
|
| 6/26/2019 | SP | New Issue: CIBC sells $133,000 notes tied to 14 Raymond James Healthcare top picks
|
| 6/26/2019 | SP | New Issue: CIBC sells $253,000 notes tied to 14 Raymond James Healthcare top picks
|
| 6/18/2019 | SP | New Issue: JPMorgan prices $1.48 million contingent interest autocallables on two stocks
|
| 6/7/2019 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 14 stocks
|
| 6/7/2019 | SP | CIBC eyes Raymond James Healthcare Top Selections notes on 14 stocks
|
| 6/4/2019 | SP | JPMorgan to price contingent interest autocallables on two stocks
|
| 5/30/2019 | SP | New Issue: CIBC sells $370,000 Raymond James Healthcare Top Selections notes on 15 stocks
|
| 5/30/2019 | SP | New Issue: CIBC sells $1.64 million Raymond James Healthcare Top Selections notes on 15 stocks
|
| 5/28/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
| 5/6/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
| 4/16/2019 | SP | New Issue: Barclays prices $1.03 million trigger autocallables linked to Boston Scientific
|
| 4/11/2019 | SP | Barclays to price trigger autocallables linked to Boston Scientific
|
| 2/25/2019 | IGLM | Boston Scientific calls 6% notes, 2.85% notes for redemption
|
| 2/22/2019 | IG | Market Commentary: NextEra Energy, Paccar tap primary market; strong deal volume eyed; Paccar firms; CBS flat
|
| 2/21/2019 | EMHYPFPV | Market Commentary: Boston Scientific, CSX, Weyerhaeuser, Florida Power, Sweden price; Woodside holds roadshow
|
| 2/21/2019 | IG | Market Commentary: Boston Scientific, CSX, Weyerhaeuser, Florida Power, Sweden price; Woodside holds roadshow
|
| 2/21/2019 | IG | New Issue: Boston Scientific prices $4.3 billion of senior notes in five parts
|
| 2/21/2019 | IGLM | Boston Scientific to redeem 6% notes, 2.85% notes via new notes
|
| 2/21/2019 | BK | Boston Scientific to repay term loan with funds from new notes
|
| 2/21/2019 | BKIG | Moody's rates Boston Scientific notes Baa2
|
| 2/21/2019 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 2/21/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
| 2/21/2019 | IG | Market Commentary: Morning Commentary: Boston Scientific, CSX, Weyerhaeuser, Florida Power, Sweden on tap
|
| 2/21/2019 | IG | Boston Scientific offers $4.3 billion fixed-rate notes in five parts
|
| 12/21/2018 | BK | Boston Scientific gets $2.75 billion revolver, $2 billion term loans
|
| 11/21/2018 | BKIG | S&P affirms Boston Scientific
|
| 11/20/2018 | BKIG | Boston Scientific plans to incur debt for £3.3 billion buyout of BTG
|
| 8/30/2018 | BKIG | S&P revises Boston Scientific view to positive
|
| 8/21/2018 | BKIG | Fitch gives Boston Scientific loan BBB
|
| 8/21/2018 | BK | Boston Scientific gets $1 billion 364-day term loan via Wells Fargo
|
| 8/16/2018 | BKIG | Fitch affirms Boston Scientific
|
| 4/2/2018 | SP | New Issue: CIBC sells $495,000 notes on eight Raymond James top pick healthcare stocks
|
| 4/2/2018 | SP | New Issue: CIBC sells $285,000 Raymond James Healthcare Top Selections notes on 16 stocks
|
| 4/2/2018 | SP | New Issue: CIBC sells $548,000 notes on eight Raymond James top pick healthcare stocks
|
| 3/20/2018 | SP | CIBC plans notes on eight Raymond James top pick healthcare stocks
|
| 3/20/2018 | SP | CIBC to price notes on eight Raymond James top pick healthcare stocks
|
| 3/20/2018 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 16 stocks
|
| 3/20/2018 | SP | CIBC to price notes on 16 Raymond James top pick healthcare stocks
|
| 2/22/2018 | EMHYPFPV | Market Commentary: High-grade supply robust; BNP, Kinder Morgan, American Express, Deutsche among issuers
|
| 2/22/2018 | IG | Market Commentary: High-grade supply robust; BNP, Kinder Morgan, American Express, Deutsche among issuers
|
| 2/22/2018 | IG | New Issue: Boston Scientific prices $1 billion 4% 10-year notes at 110 bps over Treasuries
|
| 2/22/2018 | BKIG | Fitch gives Boston Scientific notes BBB
|
| 2/22/2018 | BKIG | Moody’s rates Boston Scientific notes Baa2
|
| 2/22/2018 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 2/22/2018 | IG | Market Commentary: Morning Commentary: Highwoods firms deal details; American Express, Kinder Morgan on deck
|
| 2/22/2018 | IG | Boston Scientific plans to conduct offering of senior notes
|
| 8/7/2017 | BK | Boston Scientific enters $2.25 billion replacement credit facility
|
| 7/28/2017 | BKIG | S&P: Boston Scientific view to stable
|
| 6/16/2017 | BKIG | Fitch ups Boston Scientific, facility, notes to BBB
|
| 6/13/2017 | BKIG | S&P gives Boston Scientific short-term A-3
|
| 2/10/2017 | BK | Boston Scientific expands revolver to $400 million, extends it to 2019
|
| 12/7/2016 | BKIG | Moody’s raises Boston Scientific to Baa2
|
| 1/21/2016 | SP | Barclays plans contingent income autocallables on Boston Scientific
|
| 5/7/2015 | EMHYMUPFPV | Market Commentary: Week’s supply tops $50 billion; Boston Scientific, Chevron Phillips price; AbbVie tight
|
| 5/7/2015 | IG | Market Commentary: Week’s supply tops $50 billion; Boston Scientific, Chevron Phillips price; AbbVie tight
|
| 5/7/2015 | IG | New Issue: Boston Scientific prices $1.85 billion of notes in tranches due 2020, 2022, 2025
|
| 5/7/2015 | IGLM | Boston Scientific to redeem some 5.5%, 6.4% notes with note proceeds
|
| 5/7/2015 | BKIG | Moody’s rates Boston Scientific notes Baa3
|
| 5/7/2015 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 5/7/2015 | BKIG | Fitch rates Boston Scientific notes BBB-
|
| 5/7/2015 | IG | Boston Scientific sets talk, to sell notes in three tranches Thursday
|
| 4/16/2015 | BKIG | S&P assigns BBB- to Boston Scientific loans
|
| 4/14/2015 | BK | Boston Scientific gets $2 billion revolver at Libor plus 130 bps
|
| 3/2/2015 | BKIG | S&P: Boston Scientific view now negative
|
| 3/2/2015 | BK | Boston Scientific to obtain new credit facility to fund acquisition
|
| 2/18/2015 | BKIG | S&P affirms Boston Scientific on settlement news
|
| 12/19/2014 | SP | New Issue: UBS prices $175,000 trigger phoenix autocallable optimization securities linked to Boston Scientific
|
| 9/11/2013 | IGLM | Boston Scientific calls entire $1.45 billion of 5.45%, 4.5% notes
|
| 8/13/2013 | BK | Boston Scientific gets $400 million term loan at Libor plus 150 bps
|
| 8/12/2013 | IG | Market Commentary: Midday Commentary: Ford, Wells Fargo firm, Procter & Gamble eases
|
| 8/9/2013 | IG | Market Commentary: Midday Commentary: Boston Scientific five-year notes tighten; Procter & Gamble eases
|
| 8/8/2013 | IG | New Issue: Boston Scientific sells $1.05 billion notes in five-, 10-year tranches
|
| 8/8/2013 | IG | Market Commentary: Investment-grade primary sees 'surprise rush' of new deals; secondary focuses on new issues
|
| 8/8/2013 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 8/8/2013 | IGLM | Boston Scientific to redeem 5.45%, 4.5% notes via offerings proceeds
|
| 8/8/2013 | BKIG | Moody's gives Boston Scientific notes Baa3
|
| 8/8/2013 | BKIG | Fitch rates Boston Scientific notes BBB-
|
| 8/8/2013 | IG | Boston Scientific planning two-tranche offering of senior notes
|
| 7/1/2013 | BK | Boston Scientific cuts receivables loans to $350 million, extends term
|
| 7/19/2012 | BKIG | Fitch affirms Boston Scientific
|
| 5/22/2012 | SP | New Issue: RBC prices $831,100 trigger phoenix autocallables linked to Boston Scientific
|
| 5/16/2012 | SP | RBC plans 9.5%-12.5% trigger phoenix notes tied to Boston Scientific
|
| 4/19/2012 | BK | Boston Scientific cuts pricing with new $2 billion five-year revolver
|
| 3/9/2012 | IG | Moody's: Boston Scientific unaffected
|
| 3/9/2012 | IG | S&P affirms Boston Scientific
|
| 2/22/2012 | SP | New Issue: JPMorgan prices $1.71 million trigger phoenix autocallables tied to Boston Scientific
|
| 2/14/2012 | SP | JPMorgan plans trigger phoenix autocallables tied to Boston Scientific
|
| 2/13/2012 | IG | Moody's ups Boston Scientific
|
| 11/8/2011 | SP | New Issue: Deutsche Bank prices $696,906 10.5% trigger yield optimization notes on Boston Scientific
|
| 11/1/2011 | SP | Deutsche Bank plans 8%-10.75% trigger yield optimization notes linked to Boston Scientific
|
| 10/28/2011 | HY | Market Commentary: Ford Credit ends big primary week with $1.25 billion drive-by; MF Global dives after downgrade
|
| 10/3/2011 | SP | Bank of Montreal plans 15% reverse exchangeables on Boston Scientific
|
| 9/16/2011 | SP | New Issue: Bank of Montreal prices $323,000 17.47% reverse exchangeables tied to Boston Scientific
|
| 8/30/2011 | SP | New Issue: Barclays prices $100,000 10% reverse convertibles linked to Boston Scientific
|
| 8/3/2011 | SP | Barclays to price 10% reverse convertibles linked to Boston Scientific
|
| 7/21/2011 | BKHYIG | Fitch lifts Boston Scientific from junk
|
| 5/24/2011 | SP | New Issue: UBS prices $4.97 million trigger phoenix autocallables tied to Boston Scientific
|
| 5/17/2011 | SP | UBS to price trigger phoenix autocallables linked to Boston Scientific
|
| 1/3/2011 | IGLM | Boston Scientific redeems $600 million of 6% notes due 2011 in full
|
| 12/2/2010 | SP | Deutsche Bank changes payout at maturity for $1.31 million autocallables linked to three stocks
|
| 11/30/2010 | SP | New Issue: Deutsche Bank prices $1.31 million autocallables tied to three stocks
|
| 11/29/2010 | SP | New Issue: RBC prices $124,000 11.25% reverse convertibles linked to Boston Scientific
|
| 11/8/2010 | SP | RBC to price 11.25% reverse convertibles linked to Boston Scientific
|
| 10/29/2010 | IG | Moody's lifts Boston Scientific
|
| 10/29/2010 | IG | Fitch: Boston Scientific outlook positive
|
| 10/28/2010 | SP | New Issue: RBC prices $299,000 11.5% reverse convertibles linked to Boston Scientific
|
| 10/21/2010 | SP | RBC to price 11.5% reverse convertibles linked to Boston Scientific
|
| 6/23/2010 | IGLM | Boston Scientific to repay $850 million of notes with loan proceeds
|
| 6/22/2010 | SP | New Issue: Barclays prices $1.3 million autocallable notes on worst performing component of stock basket
|
| 5/17/2010 | SP | New Issue: RBC prices $0.04 million 16.25% reverse convertibles linked to Boston Scientific
|
| 5/12/2010 | SP | RBC increases coupon for RevCons linked to Boston Scientific to 16.25%
|
| 5/11/2010 | SP | Barclays to price 10.5% reverse convertibles linked to Boston Scientific
|
| 5/6/2010 | SP | New Issue: UBS prices $8.92 million 14.43% yield optimization notes tied to Boston Scientific
|
| 5/6/2010 | SP | UBS plans 11.36% reverse convertibles linked to Boston Scientific
|
| 5/4/2010 | SP | RBC to price 13.25% reverse convertibles linked to Boston Scientific
|
| 4/30/2010 | SP | New Issue: RBC prices $0.28 million 10% reverse convertibles linked to Boston Scientific
|
| 4/30/2010 | SP | UBS plans 11.5%-13.5% yield optimization notes on Boston Scientific
|
| 4/29/2010 | SP | New Issue: Barclays prices $1 million 11% reverse convertibles linked to Boston Scientific
|
| 4/28/2010 | SP | New Issue: RBS prices $0.06 million 12% reverse convertibles linked to Boston Scientific
|
| 4/22/2010 | SP | RBC plans 10% reverse convertibles linked to Boston Scientific
|
| 4/19/2010 | SP | New Issue: RBC sells $445,000 13% reverse convertibles linked to Boston Scientific
|
| 4/13/2010 | SP | RBS to price 12% reverse convertibles linked to Boston Scientific
|
| 4/12/2010 | SP | Barclays to price 11% reverse convertibles linked to Boston Scientific
|
| 4/1/2010 | SP | RBC plans 13% reverse convertibles linked to Boston Scientific stock
|
| 3/31/2010 | SP | New Issue: Barclays prices $4 million 9% reverse convertibles linked to Boston Scientific
|
| 3/30/2010 | SP | New Issue: RBC prices $215,000 13% reverse convertibles linked to Boston Scientific
|
| 3/22/2010 | SP | RBC to price 13% reverse convertibles linked to Boston Scientific
|
| 3/16/2010 | HY | Market Commentary: Upsized U.S. Steel prices, Digicel also; market awaits BioScrip; new Bombardiers keep rising
|
| 3/16/2010 | IG | Market Commentary: First Niagara, Developers Diversified price deals, Hartford plans sale; banks trade firmer
|
| 3/16/2010 | SP | New Issue: Barclays prices $1.17 million 17.4% reverse convertibles linked to Boston Scientific
|
| 3/15/2010 | BKHY | Moody's: No change for Boston Scientific
|
| 3/15/2010 | HY | Market Commentary: Upsized Bombardier two-part prices, gains; Digicel, RadNet, Wyle slate, Boston Scientific off
|
| 3/15/2010 | HY | Market Commentary: Upsized Bombardier two-part prices, gains; Digicel, RadNet, Wyle slate, Boston Scientific off
|
| 3/15/2010 | IG | Market Commentary: Commonwealth Bank, EIB, Entergy price bonds; trading volume down, Boston Scientific widens
|
| 3/15/2010 | IG | Market Commentary: Commonwealth Bank, EIB, Entergy price bonds; trading volume down, Boston Scientific widens
|
| 3/9/2010 | SP | Barclays to price 9% reverse convertibles linked to Boston Scientific
|
| 3/2/2010 | SP | New Issue: Barclays prices $10 million more 9.25% reverse convertibles linked to Boston Scientific
|
| 2/19/2010 | SP | New Issue: Barclays prices $5 million more 9.25% reverse convertibles linked to Boston Scientific
|
| 2/1/2010 | BKHY | Moody's affirms Boston Scientific
|
| 2/1/2010 | HY | Market Commentary: Severstal Columbus, NFR, ITC slate deals; new Appletons continue slide; Blockbuster down more
|
| 2/1/2010 | IG | Market Commentary: Procter & Gamble sells bonds, UDR reopens notes, new deals to increase; P&G gains in secondary
|
| 2/1/2010 | BKHY | Fitch: Boston Scientific view to stable
|
| 1/20/2010 | SP | New Issue: Barclays prices $5 million more 9.5% reverse convertibles linked to Boston Scientific
|
| 12/11/2009 | IG | Market Commentary: TIAA prices 30-year; Boston Scientific tranches in sharply, Citigroup, Time Warner active
|
| 12/10/2009 | HY | Market Commentary: Bumble Bee, upsized American Axle, Wind deals price, new debt trades up; funds gain $324 million
|
| 12/10/2009 | HYIG | New Issue: Boston Scientific sells $2 billion split-rated notes in three tranches
|
| 12/10/2009 | IG | Market Commentary: Boston Scientific, Caterpillar, American Transmission tap high-grade market; Citi tightens
|
| 12/10/2009 | BKHY | Moody's rates Boston Scientific notes Ba1
|
| 12/10/2009 | BKHY | Fitch rates Boston Scientific notes BB+
|
| 12/10/2009 | HY | Boston Scientific files automatic shelf for senior, subordinated debt
|
| 11/30/2009 | SP | New Issue: Barclays prices $1 million 9.25% reverse convertibles linked to Boston Scientific
|
| 11/10/2009 | SP | Barclays to price 9.25% reverse convertibles linked to Boston Scientific
|
| 9/29/2009 | SP | New Issue: Barclays prices $2 million 9.5% reverse convertibles linked to Boston Scientific
|
| 9/10/2009 | SP | Barclays to price 9.5% reverse convertibles linked to Boston Scientific
|
| 6/3/2009 | SP | Barclays to price 11.25% reverse convertibles linked to Boston Scientific
|
| 5/28/2009 | SP | New Issue: Barclays prices $2.5 million 11% reverse convertibles linked to Boston Scientific
|
| 5/19/2009 | BKHY | Fitch affirms Boston Scientific
|
| 5/15/2009 | SP | Barclays to price 11% reverse convertibles linked to Boston Scientific
|
| 3/30/2009 | SP | New Issue: Barclays prices $3 million 13.75% reverse convertibles linked to Boston Scientific
|
| 3/25/2009 | BKHY | S&P: Boston Scientific view positive
|
| 3/16/2009 | SP | Barclays to price 13.75% reverse convertibles linked to Boston Scientific
|
| 3/10/2009 | BKHY | Moody's ups Boston Scientific outlook to stable
|
| 2/26/2009 | SP | Barclays to price 13.25% reverse convertibles linked to Boston Scientific
|
| 2/26/2009 | BK | Boston Scientific amends loan, revising covenants and pricing
|
| 10/7/2008 | BKHY | S&P: Boston Scientific unchanged
|
| 8/13/2008 | SP | Barclays to price 10.75% reverse convertibles linked to Boston Scientific
|
| 6/27/2008 | SP | New Issue: Barclays prices $3.5 million 10.5% reverse convertibles linked to Boston Scientific
|
| 6/11/2008 | SP | Barclays to price 10.5% reverse convertibles linked to Boston Scientific
|
| 6/4/2008 | BKHY | Fitch: Boston Scientific view stable
|
| 5/28/2008 | SS | Boston Scientific acquires CryoCor for $17.6 million
|
| 5/9/2008 | BK | Boston Scientific prepays $625 million of term debt
|
| 5/7/2008 | SP | Fortis to price 10.1% knock-in reverse convertibles linked to Boston Scientific
|
| 4/16/2008 | SS | Boston Scientific to acquire CryoCor for $17.6 million
|
| 2/28/2008 | SP | New Issue: Barclays prices $3 million 14% reverse convertibles linked to Boston Scientific
|
| 2/26/2008 | SP | New Issue: JPMorgan prices $1 million 11.95% notes linked to Medtronic, Boston Scientific
|
| 2/11/2008 | SP | Barclays to price 14% reverse convertibles linked to Boston Scientific
|
| 1/8/2008 | BKHY | S&P: Boston Scientific unchanged
|
| 11/29/2007 | SP | New Issue: Barclays prices $1.5 million 14% reverse convertibles linked to Boston Scientific
|
| 11/8/2007 | SP | Barclays to price 14% reverse convertibles linked to Boston Scientific
|
| 10/30/2007 | SP | New Issue: Barclays prices $1.5 million 15.25% reverse convertibles linked to Boston Scientific
|
| 10/19/2007 | BKHY | S&P: Boston Scientific outlook negative
|
| 10/19/2007 | CV | Market Commentary: Gilead falls after positive earnings; Medtronic drags down St. Jude; AMD weighs down Intel; Yahoo! gives back
|
| 10/17/2007 | SS | Boston Scientific restructuring includes staff cuts, possible sale of business units
|
| 10/10/2007 | SP | Barclays to price 15.25% reverse convertibles linked to Boston Scientific
|
| 9/27/2007 | SP | New Issue: Barclays prices $1.5 million 14.5% reverse convertibles linked to Boston Scientific
|
| 9/12/2007 | SP | Barclays to price 14.5% reverse convertibles linked to Boston Scientific
|
| 9/4/2007 | HY | Market Commentary: Marketeers back from break, but not much happening; Leap unit jumps on merger bid; mortgage names up
|
| 8/31/2007 | SP | New Issue: Barclays prices $1 million 13.15% reverse convertibles linked to Boston Scientific
|
| 8/24/2007 | BKHY | S&P keeps Boston Scientific on watch
|
| 8/23/2007 | BK | Boston Scientific amends loan, extending leverage ratio step-down, revising EBITDA definition
|
| 8/23/2007 | HY | Market Commentary: Countrywide up after B of A deal, ResCap gyrates; primary quiet; funds see $380 million outflow
|
| 8/8/2007 | SP | Barclays to price 13.15% reverse convertibles linked to Boston Scientific
|
| 8/3/2007 | SP | New Issue: Societe Generale sells $2.5 million 14% Tempo ReConvs linked to Boston Scientific
|
| 8/3/2007 | BKHY | S&P lowers Boston Scientific to junk
|
| 8/3/2007 | BKHY | Fitch cuts Boston Scientific to junk
|
| 8/3/2007 | HY | Market Commentary: Chiquita bonds lower on numbers; semiconductors strong; primary quiet
|
| 8/3/2007 | IG | Volatile conditions continue to hamper investment grade trading at end of week with few new issues
|
| 8/2/2007 | SS | Boston Scientific will not spin off endosurgery group as part of its restructuring plan
|
| 7/26/2007 | SP | New Issue: Barclays prices $1.5 million 14% reverse convertibles linked to Boston Scientific
|
| 7/26/2007 | SP | New Issue: Natixis prices $130,000 11.7% reverse convertibles linked to Boston for Eksportfinans
|
| 7/24/2007 | HY | Moody's drops Boston Scientific to junk
|
| 7/23/2007 | HY | S&P lowers Boston Scientific
|
| 7/18/2007 | SP | New Issue: Deutsche Bank prices $2 million 13.35% notes linked to Boston Scientific, Stewart Enterprises
|
| 7/13/2007 | SP | Societe Generale to price 14% Tempo ReConvs linked to Boston Scientific
|
| 7/10/2007 | SP | Barclays to price 14% reverse convertibles linked to Boston Scientific
|
| 7/2/2007 | SP | Natixis to price 11.7% reverse convertibles linked to Boston Scientific for Eksportfinans
|
| 6/29/2007 | SP | New Issue: Barclays prices $2 million 10.5% reverse convertibles linked to Boston Scientific
|
| 6/28/2007 | SP | New Issue: ABN Amro sells $1.475 million 10.5% knock-in notes linked to Boston Scientific
|
| 6/27/2007 | SP | New Issue: UBS prices $11 million 12.17% yield optimization notes linked to Boston Scientific
|
| 6/8/2007 | SP | Barclays to price 10.5% reverse convertibles linked to Boston Scientific
|
| 6/5/2007 | SP | ABN Amro plans 10.5% Knock-in Reverse Exchangeables linked to Boston Scientific
|
| 6/4/2007 | SP | New Issue: SG Structured Products prices $2 million 11% ReConvs linked to Boston Scientific
|
| 6/1/2007 | SP | UBS to price yield optimization notes linked to Boston Scientific
|
| 5/29/2007 | SP | New Issue: Barclays prices $1 million 11.35% reverse convertibles linked to Boston Scientific
|
| 5/29/2007 | SP | New Issue: Barclays prices $4.5 million 12.8% reverse convertibles linked to Boston Scientific
|
| 5/9/2007 | SP | Barclays to price 12.8% six-month reverse convertibles linked to Boston Scientific
|
| 5/9/2007 | SP | Societe Generale to price 11% ReConvs linked to Boston Scientific
|
| 5/3/2007 | SP | Barclays to price 11.35% six-month reverse convertibles linked to Boston Scientific
|
| 4/27/2007 | SP | New Issue: RBC sells $598,000 10.5% reverse convertibles linked to Boston Scientific
|
| 4/26/2007 | SP | New Issue: Credit Suisse sells $851,000 10.45% reverse convertibles linked to Boston Scientific
|
| 4/24/2007 | SP | New Issue: Barclays sells $2.5 million 12.1% six-month reverse convertibles linked to Boston Scientific
|
| 4/24/2007 | SP | New Issue: Citigroup prices $67.2 million 8.8% ELKS linked to Boston Scientific
|
| 4/16/2007 | SP | RBC to price 10.5% reverse convertibles linked to Boston Scientific
|
| 4/5/2007 | SP | Credit Suisse to price 10.45% reverse convertibles linked to Boston Scientific
|
| 4/4/2007 | SP | Barclays to price 12.1% reverse convertibles linked to Boston Scientific
|
| 4/3/2007 | SP | New Issue: SG Structured Products prices $1.75 million 10.5% ReConvs linked to Boston Scientific
|
| 3/8/2007 | SP | Societe Generale to price 10.5% ReConvs linked to Boston Scientific
|
| 2/26/2007 | SP | New Issue: Barclays prices $2 million 9.25% notes linked to Boston Scientific
|
| 2/6/2007 | SP | Barclays to price 9.25% reverse convertibles linked to Boston Scientific
|
| 2/1/2007 | SP | New Issue: Wachovia sells $4.57 million 9% enhanced yield securities linked to Boston Scientific
|
| 1/5/2007 | SP | Societe Generale to price 10.5% ReConvs linked to Boston Scientific
|
| 1/3/2007 | SP | Wachovia to price enhanced yield securities linked to Boston Scientific
|
| 12/13/2006 | SP | New Issue: Societe Generale sells $3.25 million of 10% ReConvs linked to Boston Scientific
|
| 11/22/2006 | SP | New Issue: JPMorgan sells $482,000 11.5% reverse exchangeables linked to Boston Scientific
|
| 11/21/2006 | SP | New Issue: Barclays sells $2.5 million 12.8% notes linked to Boston Scientific
|
| 11/7/2006 | BT | Boston Scientific at outperform by Bear Stearns
|
| 11/7/2006 | BT | RBC puts Boston Scientific at sector perform
|
| 11/6/2006 | SP | Societe Generale to price 10% ReConvs linked to Boston Scientific
|
| 11/3/2006 | SP | JPMorgan to price 11.5% reverse exchangeables linked to Boston Scientific
|
| 10/24/2006 | SP | Barclays to price 12.8% reverse convertibles linked to Boston Scientific
|
| 10/19/2006 | BT | Boston Scientific maintained at sector perform by RBC
|
| 10/2/2006 | SP | LaSalle to price 11% reverse convertibles linked to Boston Scientific for Rabo
|
| 9/29/2006 | SP | New Issue: Credit Suisse prices $382,000 of 8.5% reverse convertibles linked to Boston Scientific
|
| 9/26/2006 | BT | S&P lowers Boston Scientific outlook to negative
|
| 9/22/2006 | BT | Boston Scientific at market perform
|
| 9/22/2006 | BT | RBC maintains Boston Scientific at sector perform
|
| 9/8/2006 | BT | S&P: Boston Scientific unchanged
|
| 9/8/2006 | BT | JMP keeps Boston Scientific at market perform
|
| 9/7/2006 | CV | Credit Suisse to sell 8.5% reverse convertibles linked to Boston Scientific
|
| 9/6/2006 | BT | Boston Scientific: Taxus stent shows excellent long-term outcomes in coronary artery disease
|
| 9/5/2006 | BT | Boston Scientific: Olympia trial meets endpoint
|
| 9/5/2006 | BT | Boston Scientific maintained at market perform
|
| 9/1/2006 | BT | Boston Scientific to launch Promus stent system
|
| 7/31/2006 | BT | Boston Scientific kept at market perform by JMP
|
| 7/31/2006 | BT | St. Jude Medical, Boston Scientific settle litigation related to four patents
|
| 7/28/2006 | BT | Boston Scientific maintained at sector perform by RBC
|
| 7/27/2006 | BT | Boston Scientific second-quarter net sales up 31% at $2.11 billion
|
| 7/24/2006 | BT | Boston Scientific reports efficacy for Taxus Liberte stent system
|
| 7/5/2006 | BT | Boston Scientific cut to market perform
|
| 6/28/2006 | BT | S&P: Boston Scientific unchanged
|
| 6/27/2006 | BT | RBC puts Boston Scientific at sector perform
|
| 6/23/2006 | BT | RBC puts Boston Scientific at sector perform
|
| 6/22/2006 | BT | JMP keeps Boston Scientific at strong buy
|
| 6/20/2006 | BT | Study shows closed cell design of Boston Scientific's Carotid Wallstent Monorail offers superior outcomes
|
| 6/15/2006 | BT | Cordis to appeal court ruling upholding Boston Scientific stent patent
|
| 6/12/2006 | BT | Boston Scientific data shows 'excellent' outcomes for Taxus stent in diabetics
|
| 6/7/2006 | BT | New Issue: Boston Scientific prices $1.2 billion 5, 10-year notes
|
| 6/6/2006 | BT | Boston Scientific to market new balloon catheters
|
| 6/6/2006 | BT | S&P rates Boston Scientific notes BBB+
|
| 6/6/2006 | BT | Moody's rates Boston Scientific notes Baa3
|
| 6/6/2006 | BT | Fitch rates Boston Scientific notes BBB
|
| 5/31/2006 | BT | Boston Scientific gets FDA clearance for system for removing clots from arteries
|
| 5/26/2006 | BT | Court rules Boston Scientific's products do not infringe Medtronic stent patents
|
| 5/22/2006 | BT | Boston Scientific: study shows benefits of dual-chamber pacing in implantable cardioverter defibrillators
|
| 5/19/2006 | BT | Boston Scientific studies wireless home-monitoring system for heart-failure patients
|
| 5/17/2006 | BT | Boston Scientific's Taxus coronary stent system cited for diabetic patients
|
| 5/17/2006 | BT | Boston Scientific to build Brussels education center to train doctors
|
| 5/16/2006 | BT | Boston Scientific's Taxus Liberte stent system CE mark approval expanded
|
| 5/16/2006 | BT | Three-year follow-up data supports safety, efficacy of Boston Scientific's Taxus Express stent
|
| 5/11/2006 | BT | Court upholds decisions in Boston Scientific, Johnson & Johnson patent case
|
| 5/11/2006 | BT | Cardium wins patent suit against Boston Scientific, Arch Development
|
| 5/10/2006 | BT | Boston Scientific, BioForm Medical get FDA approval for incontinence product
|
| 5/4/2006 | BT | Boston Scientific sues Conor Medsystems Ireland
|
| 5/1/2006 | BT | Boston Scientific adds to line of Vasoview vessel harvesting line with launch of two products
|
| 4/26/2006 | BT | Boston Scientific gets $7 billion credit facility
|
| 4/21/2006 | BT | S&P drops Boston Scientific
|
| 4/21/2006 | BT | Moody's cuts Boston Scientific
|
| 4/21/2006 | BT | Fitch lowers Boston Scientific
|
| 4/21/2006 | BT | Boston Scientific ups coupon on senior notes due 2015, 2035 by 75 bps
|
| 4/19/2006 | BT | JMP keeps Boston Scientific at strong buy
|
| 4/18/2006 | BT | Boston Scientific says sales reach record $1.62 billion in 1Q06
|
| 4/17/2006 | BT | Boston Scientific: Pulse generator for migraine treatment implanted in first patient
|
| 4/17/2006 | BTCV | New Issue: Lehman prices $100.4 million 7.5% Yeelds linked to Boston Scientific
|
| 4/6/2006 | BT | JMP reiterates Boston Scientific at strong buy
|
| 4/3/2006 | BT | Boston Scientific gets FDA clearance for new catheter tube
|
| 3/29/2006 | BT | Cardium announces patent wins over Boston Scientific, Arch Development
|
| 3/29/2006 | BT | Boston Scientific kept at strong buy by JMP
|
| 3/27/2006 | BT | Cordis says district judge upholds patent infringement verdicts against Boston Scientific, Medtronic
|
| 3/22/2006 | BTCV | Boston Scientific files automatic shelf
|
| 3/15/2006 | BT | Boston Scientific notes JAMA article indicates Taxus stents superior to brachytherapy
|
| 3/14/2006 | BT | Angiotech, Boston Scientific's registry results confirm safety of Taxus stent
|
| 3/14/2006 | BT | Market Commentary: PharmAthene going public via Siga merger; Corautus crashes, deal nixed; Novavax, Generex up
|
| 3/13/2006 | BT | Boston Scientific: Results of two studies favor Taxus stent over Cypher in some patients
|
| 2/23/2006 | BT | S&P keeps Boston Scientific on negative watch
|
| 2/13/2006 | BT | Moody's cuts Boston Scientific, may lower Guidant
|
| 2/10/2006 | BT | Fitch to lower Boston Scientific
|
| 2/8/2006 | BT | JMP rates Boston Scientific at strong buy
|
| 1/30/2006 | BT | Boston a strong buy for JMP
|
| 1/26/2006 | BT | FDA cites regulatory issues at Boston Scientific plants
|
| 1/25/2006 | BT | Boston Scientific, Guidant sign merger agreement valued at $27 billion
|
| 1/23/2006 | BT | Boston Scientific's stent keeps clogged arteries open in recent study
|
| 1/18/2006 | BT | Boston Scientific study demonstrates PASV Valve technology reduces occlusion, infection
|
| 1/18/2006 | BT | JMP says Boston Scientific still strong buy
|
| 1/17/2006 | BT | Boston Scientific's improved $80 per share offer accepted by Guidant
|
| 1/12/2006 | BT | Boston Scientific ups offer for Guidant
|
| 1/9/2006 | BT | Boston Scientific adds twist to $25 billion Guidant offer - selling vascular business to Abbott for $3.8 billion
|
| 1/9/2006 | BT | JMP upgrades Boston Scientific to strong buy
|
| 1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
| 12/30/2005 | BT | NitroMed, Boston Scientific end research program on nitric oxide-enhancing technology
|
| 12/8/2005 | BT | Boston Scientific still market outperform, JMP says
|
| 12/7/2005 | BT | Guidant's board to begin talks with Boston Scientific about $25 billion acquisition offer
|
| 12/6/2005 | BT | JMP ups Boston Scientific to market outperform
|
| 12/5/2005 | BT | S&P may cut Boston Scientific, up Guidant
|
| 12/5/2005 | BT | Fitch may cut Boston Scientific; Guidant view evolving
|
| 12/5/2005 | BT | Boston Scientific upgraded by JMP to market perform
|
| 12/5/2005 | BT | Boston Scientific announces interest rate step up for 51/2%, 61/4% notes on acquisition
|
| 12/5/2005 | BT | Market Commentary: Noven soars on ADHD patch news; Ligand bounces on board expansion; Progenics off sharply
|
| 12/5/2005 | BT | Boston Scientific offers $25 billion to buy Guidant, topping Johnson & Johnson's offer
|
| 12/5/2005 | BT | Moody's may lower Boston Scientific
|
| 11/29/2005 | BT | Boston Scientific says independent study shows Taxus stent performs better than Cypher
|
| 11/14/2005 | BT | Fitch rates Boston Scientific notes A
|
| 11/14/2005 | BT | S&P assigns Boston Scientific notes A
|
| 11/14/2005 | BT | Moody's gives Boston Scientific notes A3
|
| 11/10/2005 | BT | Boston Scientific to begin trial of Precision neurostimulator to treat migraine headaches
|
| 11/10/2005 | BT | Moody's ups Boston Scientific
|
| 11/9/2005 | BT | Boston Scientific gets FDA approval of Artisan Surgical Lead
|
| 10/25/2005 | BT | Independent Stent registry shows Taxus Stent to be effective
|
| 10/24/2005 | BT | Boston Scientific acquires proprietary stent technologies from Rusch
|
| 10/24/2005 | BT | JMP maintains Boston Scientific's underperform
|
| 10/17/2005 | BT | JMP: Boston Scientific still at underperform
|
| 9/26/2005 | BT | S&P: Boston Scientific unaffected
|
| 9/22/2005 | BT | Fitch affirms Boston Scientific
|
| 9/8/2005 | BT | Boston Scientific price target cut by Bear
|
| 9/7/2005 | BT | Boston Scientific kept by JMP at under perform
|
| 9/6/2005 | BTCV | New Issue: Goldman Sachs prices $15 million 1.2% notes mandatorily exchangeable for Boston Scientific
|
| 8/23/2005 | BT | Boston Scientific kept by JMP at market underperform
|
| 8/18/2005 | BT | Boston Scientific held at underperform by JMP
|
| 8/5/2005 | BT | S&P raises Boston Scientific
|
| 7/6/2005 | BTCV | New Issue: ABN Amro sells $575,000 8.25% reverse exchangeables linked to Boston Scientific
|
| 7/5/2005 | BT | Market Commentary: Voyager plans IPO; Able Labs plunges; Mylan Labs launch seen; Boston Scientific up, J&J lower
|
| 7/5/2005 | BTCV | S&P: Verdict supports Boston Scientific
|
| 6/22/2005 | BT | Fitch: Boston Scientific unchanged
|
| 6/21/2005 | BT | S&P: Boston Scientific unaffected
|
| 3/23/2005 | CV | New Issue: Barclays sells $1.5 million 8.50% exchangeables linked to Boston Scientific
|
| 3/9/2005 | CV | New Issue: ABN Amro sells $725,000 9.25% reverse exchangeables linked to Boston Scientific
|
| 11/24/2004 | CV | New Issue: ABN Amro sells $4.9 million 9% reverse exchangeables linked to Boston Scientific
|
